Review
Open access
Sep 2026
The Landmark Series: Mutation-Based Therapy of Pancreatic Cancer.
BACKGROUND Pancreatic ductal adenocarcinoma (PDAC) remains a highly lethal malignancy with limited long-term survival despite advances in surgery and systemic therapy. PATIENTS The population of interest comprises patients with PDAC characterized by targetable molecular alterations and biologically distinct transcrip...
McKenzie L. Schaefer, Susan Tsai, Alex B. Blair
· Annals of Surgical Oncology · 0 citations